Economic analysis of vancomycin-resistant enterococci at a Canadian hospital: assessing attributable cost and length of stay
- 1 September 2013
- journal article
- Published by Elsevier BV in Journal of Hospital Infection
- Vol. 85 (1), 54-59
- https://doi.org/10.1016/j.jhin.2013.06.016
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Increased risk of vancomycin-resistant enterococcus (VRE) infection among patients hospitalized for inflammatory bowel disease in the United StatesInflammatory Bowel Diseases, 2011
- Costs Attributable to Healthcare-Acquired Infection in Hospitalized Adults and a Comparison of Economic MethodsMedical Care, 2010
- Attributable Costs of Enterococcal Bloodstream Infections in a Nonsurgical Hospital CohortInfection Control & Hospital Epidemiology, 2010
- A Cost-Benefit Analysis of Gown Use in Controlling Vancomycin-ResistantEnterococcusTransmission Is It Worth the Price?Infection Control & Hospital Epidemiology, 2004
- Effect of Nosocomial Vancomycin-Resistant Enterococcal Bacteremia on Mortality, Length of Stay, and CostsInfection Control & Hospital Epidemiology, 2003
- Health and Economic Outcomes of Vancomycin-Resistant EnterococciArchives of Internal Medicine, 2002
- Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomesIntensive Care Medicine, 2002
- Cost of Hospitalization for and Risk Factors Associated with Vancomycin‐ResistantEnterococcus faeciumInfection and ColonizationClinical Infectious Diseases, 2001
- The Incidence of and Clinical Variables Associated With Vancomycin-Resistant Enterococcal Colonization in Mechanically Ventilated PatientsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1999
- Enterococcus faecium BacteremiaArchives of Internal Medicine, 1998